Nexium Lawsuit Filed Over Stomach Cancer Diagnosis
According to allegations raised in a product liability lawsuit recently filed against AstraZeneca and Merck, side effects of Nexium resulted in the development of stomach cancer for a Georgia man.
Daniel Hudson filed the complaint (PDF) in the U.S. District Court for New Jersey on April 30, alleging that the popular acid reflux and heartburn medication increases the risk of gastric cancer, yet the drug makers failed to provide adequate warnings to consumers or the medical community.
According to the lawsuit, the link between Nexium and stomach cancer should have been anticipated as early as the late 1980s, with AstraZeneca ignoring ref flags. Rather than warning about the gastric cancer risk, the drug makers aggressively marketed Nexium, making it one of the most widely used brand-name medications on the market.
Learn More About
Nexium, Prilosec and other acid reflux drug side effects may increase risk of kidney injury. Lawsuits reviewed.Learn More About this Lawsuit See If You Qualify Now >
“When warning of the safety and risks of esomeprazole, Defendants negligently represented to the medical, healthcare, regulatory community, the Plaintiff’s prescribing and treating physicians, and the public in general, that esomeprazole had been tested and found to be safe and/or effective for its indicated use in treating peptic disorders,” the lawsuit states. “Defendants concealed their knowledge of esomeprazole’s defects, specifically the fact that it causes clinically significant hypergastrinemia and gastric cancer, from Plaintiff’s treating physicians, hospitals, pharmacies, the public in general and/or the medical and regulatory community.”
Hudson’s case will likely be centralized as part of a federal multidistrict litigation (MDL), which currently includes more than 10,300 Nexium lawsuits, Prilosec lawsuits, Prevacid lawsuits, Protonix lawsuits, Dexilant lawsuits and other claims against the makers of PPI drugs. Most of the pending claims involve allegations that the drugs caused kidney problems, but a growing number of stomach cancer lawsuits are also being filed.
In December 2013, a study published in the medical journal Gut indicated there was a link between proton pump inhibitors and gastric cancer, finding that long-term use of drugs like Nexium may double the risk.
An association was previously suspected, particularly among individuals with Helicobacter pylori (HP) infections. However, the study found that the increased risk remained even after patients received HP infection treatment.
As part of the coordinated pretrial proceedings in the federal MDL, a small group of injury lawsuits are being prepared for a series of early trial dates, which are expected to begin in late 2020. As more Nexium stomach cancer cases are brought in the coming months and years, it is likely that a separate “bellwether” process may be established to help the parties gauge how juries may respond to certain evidence and testimony that may be repeated throughout a number of claims.
LarryJanuary 2, 2020 at 2:48 pm
Had surgery for esphoguas cancer in 2018
SammieAugust 14, 2019 at 11:10 pm
Had surgery on stomach for cancer
"*" indicates required fields
More Top Stories
Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.
More than 775 Exactech lawsuits have been filed in federal and state courts as parties work toward a plan for bellwether early test trials.
A federal judge has announced he will soon begin remanding 3M earplug lawsuits back to their originating districts for trials over claims of veteran hearing loss.